DCI reads like a classic quality compounder that the market may still be underestimating because the headline optics mix a benign cash-earning core with acquisition-related dilution. The bigger signal is not the reported EPS bridge; it is the evidence that aftermarket-heavy, installed-base revenue is offsetting softness in more cyclical first-fit pockets, which should support valuation durability even if macro industrial data stays choppy. The hidden winner is any customer tied to recurring filtration replacement demand and data-center / high-purity applications, while pure OEM industrial names with less recurring mix are more exposed to capex pauses and pricing deceleration.

Near term, the stock is vulnerable to a 'good but not clean' reaction because fiscal-year execution is heavily back-half weighted and the acquired business adds amortization/interest noise before synergies are visible. That creates a two-stage catalyst path: days-to-weeks for investors to digest the dilution, then 1-3 months for confirmation that industrial margin recovery and supply-chain normalization are actually tracking to plan. The main falsifier is any sign that margin recovery slips beyond the first half or that aerospace/power generation backlog cannot convert into shipments; that would convert a temporary execution issue into a rerating risk.

Contrarian view: consensus may be too focused on reported EPS drag and not enough on free-cash-flow quality and mix shift. If management executes on debt paydown and the recurring businesses keep comping, this can rerate higher even without heroic end-market assumptions. The trade is better framed as owning a de-risking cash compounder rather than chasing the quarter: the setup favors buying weakness, not momentum-chasing after an initial gap.